Sanofi-Aventis Groupe

Deep learning uncovers histological patterns of YAP1/TEAD activity related to disease aggressiveness in cancer patients (2025) Schmauch B, Cabeli V, Domingues OD, Le Douget JE, Hardy A, Belbahri R, Maussion C, et al. Journal article Unveiling the untreated: development of a database algorithm to identify potential Fabry disease patients in Germany (2024) Hilz MJ, Lyn N, Marczykowski F, Werner B, Pignot M, Ponce E, Bender J, et al. Journal article Patient preferences in genetic newborn screening for rare diseases: study protocol (2024) Martin S, Angolini E, Audi J, Bertini E, Bruno LP, Coulter J, Ferlini A, et al. Journal article Regulatory Issues of Platform Trials: Learnings from EU-PEARL (2024) Nguyen QL, Hees K, Hernandez Penna S, König F, Posch M, Bofill Roig M, Meyer EL, et al. Journal article, Review article Laboratory and free-living gait performance in adults with COPD and healthy controls (2023) Buekers J, Megaritis D, Koch S, Alcock L, Ammour N, Becker C, Bertuletti S, et al. Journal article Mobilizing Patient and Public Involvement in the Development of Real-World Digital Technology Solutions: Tutorial. (2023) Keogh A, Ardle RM, Diaconu MG, Ammour N, Arnera V, Balzani F, Brittain G, et al. Journal article Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement–the Mobilise-D study protocol (2022) Mikolaizak AS, Rochester L, Maetzler W, Sharrack B, Demeyer H, Mazzà C, Caulfield B, et al. Journal article Elucidation of the Application of Blood Test Biomarkers to Predict Immune-Related Adverse Events in Atezolizumab-Treated NSCLC Patients Using Machine Learning Methods (2022) Zhou JG, Wong AHH, Wang H, Tan F, Chen X, Jin SH, He SS, et al. Journal article Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project) (2022) Bernabei R, Landi F, Calvani R, Cesari M, Del Signore S, Anker SD, Bejuit R, et al. Journal article Machine learning based on blood biomarkers predicts fast progression in advanced NSCLC patients treated with immunotherapy (2022) Zhou JG, Yang J, Wang H, Wong AHH, Tan F, Chen X, He S, et al. Conference contribution